Krystal Biotech, Inc. (KRYS)

258.81 -16.83 (-6.11%) USD  |  NASDAQ  |  Mar 02, 16:00
256.00 -2.81 (-1.09%) After-Hours: 07:43
More

Krystal Biotech Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Alkermes Plc Upgrade
Stoke Therapeutics, Inc. Upgrade